CTRI/2020/05/025216已完成未知
Evaluation of Cardiac Safety of Hydroxychloroquin for pre COVID 19 Exposure Prophylaxis : Smart Remote Continuous Ambulatory Electrocardiographic Study
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- Rohit Walia
- 入组人数
- 21
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •people taking pre exposure COVID 19 hydroxychloroquin prophylaxis
- •Written informed consent
排除标准
- •Corrected QT greater than 480 ms
- •Known congenital Long QT
- •Co moralities and contraindications to hydroxychloroquin
- •Retinopathy
- •Known hypersensitivity to chloroquine
- •Cardiomyopathy, prolonged QTc, cardiac arrhythmias • History of psoriasis, porphyria cutanea tarda
- •Myasthenia gravis, myopathy of any cause
- •Serious hepatic or renal disease
- •Known glucose-6-phosphate dehydrogenase deficiency
- •Current use of medication with known serious hepatotoxic effects or known interaction with chloroquine
- •Severe depression
- •Electrolyte imbalance
- •Anti arrhythmic drugs
- •Cardiac devices like pacemaker , defibrillators
研究者
相似试验
招募中
2 期
Combination therapy in COVID 19COVID-19 pneumonia.IRCT20100228003449N30Tehran University of Medical Sciences50
已完成
3 期
study of hydroxychloroquine in comparison with pioglitazone in patients with type II diabetes mellitusCTRI/2009/091/001036Ipca Laboratories Limited267
招募中
2 期
COVID-19 prophylaxis with hydroxychloroquine in Front-line Health and Allied-Health Care Workers: The COVID-SHIELD TrialCOVID-19 infectionInfection - Other infectious diseasesRespiratory - Other respiratory disorders / diseasesACTRN12620000501943Walter and Eliza Hall Institute of Medical Research650
已完成
不适用
Efficacy and safety of hydroxychloroquine for systemic/cutaneous lupus erythematosus or Sjogren's syndrome patients with annular erythema on the face and/or trunkSystemic/cutaneous lupus erythematosus Sjogren's syndromeJPRN-UMIN000004477Kanazawa University Graduate School of Medical Science10
进行中（未招募）
不适用
Evaluation of the efficacy of hydroxychloroquine in decreasing immune activation in asymptomatic HIV-infected patients (HCQ-01) - Hydroxychloroquine studyHIV infectionMedDRA version: 9.1Level: LLTClassification code 10020161Term: HIV infectionEUCTR2007-005057-36-GBMedical Research Council